RADIOPHARMACEUTICAL THERAPY

Course overview

UAN: 0018-0000-18-202-H01-P UAN: 0018-0000-18-202-H01-T RELEASE: 10/22/2018 EXPIRE: 10/22/2021 CREDITS: 1.0 LEARNING OBJECTIVES: 1. Describe the ¿ideal¿ therapeutic radiopharmaceutical 2. Compare the clinical need with development of radioactive agents. 3. Describe the use of iodine I-131 sodium iodide in the treatment of thyroid disease including hyperthyroidism and thyroid carcinoma 4. List interventional drug therapy used to enhance the therapeutic effects of I-131 NOTE: An annual subscription for Purdue¿s nuclear pharmacy recertification program provides access to both the continuing education component of the program and the ¿Radiopharmacy Portal,¿ a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.